FDA Approves First Generic Weekly Estrogen-Progestin Patch for Menopause

The U.S. FDA has approved the first generic version of Climara Pro, a once-weekly estrogen-progestin patch for women with an intact uterus. This patch, delivering estradiol and levonorgestrel, is indicated for managing menopause symptoms and preventing bone loss. The approval aims to alleviate difficulties many women face in obtaining hormone patch prescriptions.